B

BridgeBio Oncology Therapeutics Inc
D

BBOT

10.530
USD
0.60
(6.04%)
مغلق
حجم التداول
13,572
الربح لكل سهم
-2
العائد الربحي
-
P/E
-7
حجم السوق
842,280,874
المقالات

العنوان: BridgeBio Oncology Therapeutics Inc

القطاع: Healthcare
الصناعة: Biotechnology
BridgeBio Oncology Therapeutics Inc, formerly BridgeBio Oncology Therapeutics is a clinical-stage biotechnology company that aims to transform the lives of patients with cancers driven by RAS and PI3Ka, the two frequently mutated oncogenes.